LifeAire Announces Strategic Partnership with Financing Firm to Make Pure Air Even More Accessible

2019-05-13T21:33:06+00:00 May 13th, 2019|

Consistent with LifeAire’s vision of helping healthcare facilities provide the optimal clinical environment for the benefit of their patients, LifeAire has today announced the formation of a strategic partnership with New Jersey-based Marlin Capital Solutions, a leading provider of credit products and services to small businesses.The partnership comes at a [...]

Airborne Pathogens a Topic of Increasing Interest at Life Science Conference as LifeAire Sheds Light on Impact to Gene/Cell Culture Environments

2019-04-19T13:04:17+00:00 April 17th, 2019|

After winning the Interphex Pharmaceutical Processing Editor’s Choice award last year, LifeAire Systems was happy to return to Interphex in 2019 with even stronger energy and commitment toward addressing cytotoxic airborne pathogens and their impact in manufacturing processing. We had many excellent conversations specific to the cytotoxic role of volatile organic [...]

LifeAire Systems Hosts Discussion on the Harmful Impact of VOCs on Cell Culture Viability and Expression Rates in Cell and Gene Therapies

2019-03-26T18:58:05+00:00 March 19th, 2019|

LifeAire Systems’ Founder and CEO, Dr. Kathryn C. Worrilow, is speaking at InterPhex 2019 in New York City to raise visibility to the cytotoxic role that airborne volatile organic compounds, or VOCs, play in critical life sciences cleanroom environments—such as those supporting the living cell in gene cell and immunotherapy [...]

Experience with In Vitro Fertilization Clinics Raises Strong Warnings on Cell Culture/Processing Air Purification

2018-10-30T18:07:46+00:00 October 30th, 2018|

(Originally published by Bill Paulson on July 16th, 2018 in 'International Pharmaceutical Quality (IPQ)' (https://www.ipqpubs.com). Link to original article. Reprinted with permission.)Experience with in vitro fertilization (IVF) clinics is sending a strong signal that applying significantly heightened air purification standards and more advanced technology to meet them may be critical [...]

Beyond HEPA and ULPA – The New Opportunity and Paradigm Shift in Personalized Medicine

2018-09-27T17:58:57+00:00 September 27th, 2018|

A rapid-deploy, ultra-pure cleanroom manufacturing solution with potentially disruptive impact to the industry A very informative article was recently published in Pharmaceutical Online comparing two of the most common air filters in use in pharmaceutical manufacturing and lab environments: HEPA and ULPA. The article, entitled “HEPA Versus ULPA: Which [...]

New Transformational Technology Removes the Variable of Air in BioPharma Manufacturing

2018-08-13T22:26:50+00:00 August 8th, 2018|

Last April, InterPhex 2018 served as the backdrop for the introduction of LifeAire Systems to the biopharma industry. The conference enabled air purification leader, LifeAire Systems, to introduce their transformational technology to biopharma industry manufacturing professionals seeking solutions to address emerging trends like personalized medicine driving increased focus on [...]

LifeAire Wins InterPhex Pharmaceutical Processing Editor’s Choice Award 2018

2018-04-20T17:02:17+00:00 April 17th, 2018|

LifeAire is proud to have been recognized as an innovator in life science technology by InterPhex and Pharmaceutical Processing.  LifeAire was chosen the winner of InterPhex's Editor's Choice award, sponsored by Pharmaceutical Processing. The Editor of Pharmaceutical Processing awards the Editor’s Choice Award, which is based upon her view of the [...]